Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delivery systems for hormone replacement therapy.

Ian S Fraser1, Diana Mansour

  • 1Department of Obstetrics and Gynaecology, University of Sydney, NSW 2006, Australia. helena@med.usyd.edu.au

Expert Opinion on Drug Delivery
|March 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in Adolescent and Young Adult Hospitalization for Pelvic Inflammatory Disease.

Journal of pediatric and adolescent gynecology·2025
Same author

Consensus recommendations for measuring the impact of contraception on the menstrual cycle in contraceptive clinical trials.

Contraception·2025
Same author

Real world comparison of immune-related adverse events with nivolumab-relatlimab versus ipilimumab-nivolumab in patients with advanced cutaneous melanoma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2024
Same author

The evolving perspective of menopause management in the United Kingdom.

Women's health (London, England)·2024
Same author

A novel estetrol-containing combined oral contraceptive: European expert panel review.

Ceska gynekologie·2022
Same author

Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview.

Journal of clinical medicine·2022
Same journal

Dry powder inhaler selection in COPD: integrating device design, formulation performance, and patient inspiratory capability.

Expert opinion on drug delivery·2026
Same journal

Letter to the Editor: 'saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Response to letter to the editor: 'Saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Mechanism-guided metal complex therapeutics for biofilm-driven wound infections and transdermal delivery.

Expert opinion on drug delivery·2026
Same journal

Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies.

Expert opinion on drug delivery·2026
Same journal

Drug penetration in solid tumors: influence of drug size and capillary architecture.

Expert opinion on drug delivery·2026
See all related articles

New hormone replacement therapy delivery systems offer controlled, long-term dosing for menopausal women, potentially reducing side effects compared to traditional oral methods.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Steroid hormones are crucial for hormone replacement therapy (HRT) during menopausal transition and postmenopause.
  • Oral administration is the conventional HRT route, serving as a benchmark for comparison.
  • Alternative HRT delivery systems are gaining research interest and user popularity.

Purpose of the Study:

  • To review and compare various HRT delivery systems beyond oral administration.
  • To highlight the advantages of newer delivery systems for menopausal hormone therapy.
  • To discuss the potential impact of diverse delivery options on patient acceptability and compliance.

Main Methods:

  • Review of current research and development in hormone replacement therapy delivery systems.

Related Experiment Videos

  • Analysis of attributes and potential benefits of different administration routes (transdermal, subdermal, intravaginal, intrauterine).
  • Comparison of newer systems with conventional oral therapy regarding dosage control and systemic/local effects.

    • Main Results:

    • Alternative HRT systems offer tailored dosages for local vaginal or systemic effects.
    • Newer systems provide controlled hormone delivery over extended periods, maintaining stable levels.
    • These advanced systems show potential for reduced side effects and improved metabolic profiles.

    Conclusions:

    • Emerging HRT delivery systems, including transdermal, subdermal, intravaginal, and intrauterine methods, are poised for significant development.
    • These innovative systems offer enhanced control, potentially improved safety profiles, and greater patient choice.
    • The expanding range of HRT delivery options is expected to increase acceptability and compliance among menopausal women.